Venmax Drugs And Pharmaceuticals fundamental analysis
VENMAX
16.08
0.50 (-3.02%)Last updated on 21 Aug, 2026 | 16:01 IST
Free Demat with Zero AMC*
Open a Free Demat Account
+ Free 1st Year AMC
+ Free 1st Year AMC
Venmax Drugs And Pharmaceuticals Score Card
Price
Expensive
Growth
Poor
Quality
Poor
Management
Poor
On its scorecard, Venmax Drugs And Pharmaceuticals reflects: Price – Expensive, Growth – Poor, Quality – Poor, and Management – Poor. Together, these indicators provide a structured view of the company’s fundamentals.
Venmax Drugs And Pharmaceuticals Associated Pages
- Venmax Drugs And Pharmaceuticals
Share Price - Venmax Drugs And Pharmaceuticals
Share Price chart - Venmax Drugs And Pharmaceuticals
Technical Analysis - Venmax Drugs And Pharmaceuticals
Peer Comparison - Venmax Drugs And Pharmaceuticals
Share Price History - Venmax Drugs And Pharmaceuticals
Board of Directors - Venmax Drugs And Pharmaceuticals
Shareholding Pattern
Open Your Free
Demat Account Now!
AMC for First Year
Auto Square Off Charges
Open a Free Demat Account
+ Free 1st Year AMC
+ Free 1st Year AMC
13 Lakh+ Clients
Expert-Backed
Premium Tools

Open Your Free
Demat Account Now!
AMC For First Year
Account Opening Fee
Open a Free Demat Account
+ Free 1st Year AMC
+ Free 1st Year AMC
13 Lakh+ Clients
Expert-Backed
Premium Tools
Invest in VENMAX
Account Opening Fee
AMC for 1st Year
Auto Square Off Charges
Call & Trade
Open a Free Demat Account
+ Free 1st Year AMC
+ Free 1st Year AMC